Connection

VIVEK SUBBIAH to Transaminases

This is a "connection" page, showing publications VIVEK SUBBIAH has written about Transaminases.
Connection Strength

0.233
  1. Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2020 08 27; 383(9):813-824.
    View in: PubMed
    Score: 0.186
  2. Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. N Engl J Med. 2020 08 27; 383(9):825-835.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.